Earnings Report for Novavax (NVAX) in Q2 2023

Earnings Report for Novavax (NVAX) in Q2 2023

In this illustration photo taken in Krakow, Poland on December 2, 2021, medical syringes and the Novavax logo are displayed in the background. The shares of Novavax soared by 20% in premarket trading on Tuesday following the unexpected second-quarter profit announcement by the Covid vaccine manufacturer. Novavax is working on strengthening its financial position after …

Read more

Q2 2023 Earnings Report for Eli Lilly (LLY)

Q2 2023 Earnings Report for Eli Lilly (LLY)

Sopa Images | Lightrocket | Getty Images On Tuesday, Eli Lilly, a leading pharmaceutical company, raised its full-year guidance as second-quarter profit surged 85% compared to the same period last year. The increase in profit was driven by strong sales from the company’s drug pipeline. Eli Lilly now expects full-year revenue between $33.4 billion to …

Read more

FDA Decision on Depression Drug Sends Sage Therapeutics Stock Plummeting

FDA Decision on Depression Drug Sends Sage Therapeutics Stock Plummeting

In this photo illustration, the Sage Therapeutics logo of a biopharmaceutical company seen on a smartphone and on a pc screen. Pavlo Gonchar | SOPA Images | Lightrocket | Getty Images Shares of Sage Therapeutics plummeted by more than 50% on Monday following the Food and Drug Administration’s approval of the biotech company’s oral drug, …

Read more

CDC advisors back Infant RSV shot, clearing path for fall availability

CDC advisors back Infant RSV shot, clearing path for fall availability

A child infected with RSV undergoes treatment at Missio children’s clinic Moenchberg in Wuerzburg, Germany, on December 2, 2022. Heiko Becker | Reuters An advisory panel to the Centers for Disease Control and Prevention unanimously endorsed the first shot that offers protection against respiratory syncytial virus (RSV) for infants. RSV is the leading cause of …

Read more

Q2 2023 Earnings Report for Moderna (MRNA)

Q2 2023 Earnings Report for Moderna (MRNA)

Artur Widak | Nurphoto | Getty Images Moderna, the biotech company, witnessed a rise in its stock prices after revising its full-year outlook for its Covid vaccine, which is its only marketable product. This positive development comes even though the company reported a quarterly loss and a significant drop in revenue. During the second quarter, …

Read more

Pfizer Faces Lawsuit from GSK Alleging Infringement of RSV Vaccine Patent

Pfizer Faces Lawsuit from GSK Alleging Infringement of RSV Vaccine Patent

Image: Jun Li | Istock | Getty Images GlaxoSmithKline filed a lawsuit against Pfizer in a U.S. court on Wednesday, accusing Pfizer of patent infringement for GlaxoSmithKline’s respiratory syncytial virus (RSV) vaccine. GlaxoSmithKline claims that Pfizer’s RSV vaccine, Abrysvo, violates four of its patents associated with the antigen used in GlaxoSmithKline’s own vaccine. In a …

Read more

FDA warns that Tydemy birth control pill may not be as effective

FDA warns that Tydemy birth control pill may not be as effective

Signage is visible outside the U.S. Food and Drug Administration headquarters in White Oak, Maryland, on Aug. 29, 2020. Andrew Kelly | Reuters The U.S. Food and Drug Administration (FDA) has issued a warning regarding the potential ineffectiveness of certain Tydemy birth control pills. This comes after the manufacturer recalled two batches of the medication …

Read more

Humana’s Stock Surges as Medical Costs Fall Below Expectations

Humana’s Stock Surges as Medical Costs Fall Below Expectations

A Humana office in Louisville, Kentucky, July 31, 2023. Jon Cherry | Bloomberg | Getty Images Humana shares experienced an upward surge on Wednesday as the health insurer revealed that its second-quarter earnings report showed lower-than-anticipated medical costs. This announcement alleviates investor concerns, particularly after Humana and its rival UnitedHealth Group cautioned about an increase …

Read more